-
Mashup Score: 28Dual-targeted regimens for the frontline treatment of CLL - 5 month(s) ago
Abstract. The treatment landscape of chronic lymphocytic leukemia (CLL) has evolved considerably over the past decade due to the development of effective novel
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2Diminished Humoral and Cellular Responses to SARS-CoV-2 Vaccines in Patients with Chronic Lymphocytic Leukemia - PubMed - 1 year(s) ago
Prior publications have demonstrated low rates of seroconversion to the SARS-CoV-2 mRNA vaccines in patients with chronic lymphocytic leukemia (CLL). In this national collaboration of 11 cancer centers around the United States, we aimed to further characterize and understand the vaccine-induced immu …
Source: PubMedCategories: Hem/Oncs, Latest HeadlinesTweet-
Wonderful opportunity to collaborate with my #CLL colleagues across the country. Diminished humoral/cellular responses with the #CovidVaccines . @mshadman @DebbieMStephens @KatieLaiMD_MPH @DrMDavids @DanilovLab @pongasg @KerryJL @GreningerLab https://t.co/aEPV554uxh
-
-
Mashup Score: 0
The preliminary injunction was a limited but significant victory for the Biden administration after the Justice Department sued Idaho this month.
Source: www.nytimes.comCategories: Hem/Oncs, Latest HeadlinesTweet-
https://t.co/t1fQgRVnIT
-
-
Mashup Score: 5Apply - Interfolio - 2 year(s) ago
For the Blood and Marrow Transplantation (BMT)/Immunotherapy fellowship, the Fred Hutchinson Cancer Research Center (Fred Hutch) and the University of Washington (UW) Department of Medicine, Division of Medical Oncology are jointly recruiting a full-time advanced fellow at the Research Associate/Acting Instructor (Provisional) level. This is a full-time, 12-month service period, annual…
Source: apply.interfolio.comCategories: Latest Headlines, Oncologists1Tweet-
RT @mshadman: Application for #BMT and #CART superfellowship at @fredhutch is now open: https://t.co/HXMA2DF39U @uwmnewsroom @SeattleCCA…
-
-
Mashup Score: 5Safety and efficacy of atezolizumab with obinutuzumab and bendamustine in previously untreated follicular lymphoma - 2 year(s) ago
Key Points. The addition of atezolizumab to a G-bendamustine regimen does not appear to further improve PFS in patients with previously untreated FLThe addition
Source: American Society of HematologyCategories: Hem/Oncs, Latest HeadlinesTweet-
We show increased toxicity with the addition of a PD-L1 to CIT for FL without improvement in efficacy. Reminder that we need to rethink our frontline strategies. Consider novel approaches such as @Rcl14L NCT05169658. @Cure_FL https://t.co/GJoNimSKST
-
-
Mashup Score: 1Axicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma: the phase 2 ZUMA-12 trial - Nature Medicine - 2 year(s) ago
In a phase 2 trial, first-line treatment with axicabtagene ciloleucel, an autologous CD19-targeting CAR T-cell therapy, exhibited a high complete response rate and a manageable safety profile in adults with high-risk large B-cell lymphoma.
Source: NatureCategories: Hem/Oncs, Latest HeadlinesTweet-
Zuma-12: The earliest use of #CART in #DLBCL to date. @fredhutch https://t.co/FnTAK4mc1X
-
-
Mashup Score: 0HOME - Conversations and Commentaries®: Translating Evolving Data for the Use of BTK Inhibitors in CLL Into Clinical Practice - 2 year(s) ago
Conversations and Commentaries®: Translating Evolving Data for the Use of BTK Inhibitors in CLL Into Clinical Practice.
Source: event.gotoper.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Join me and program chair, @anthonymatomd, for this CME-certified webcast on the current role of BTK inhibitors in the care of patients with CLL. Register: https://t.co/nKpif7Z7Jc #CME #hematology #CLL #BTKi @SeattleCCA @fredhutch https://t.co/HdAzMc2DLq
-
-
Mashup Score: 11The impact of B‐cell‐directed therapy on SARS‐CoV‐2 vaccine efficacy in chronic lymphocytic leukaemia - 2 year(s) ago
The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.
Source: Wiley Online LibraryCategories: Latest Headlines, Oncologists1Tweet-
Excited to show anti-S can be a surrogate for neutralization activity with #Covid vaccine in #CLL despite humoral immunodeficiency. @GreningerLab @mshadman @uwmnewsroom @CllSociety @SeattleCCA @fredhutch @LLSusa https://t.co/ImWNsTWLpw
-
-
Mashup Score: 0
The Omicron wave has been shocking. We in the virology community knew the SARS-CoV-2 virus had an exceptional ability to mutate, but the pace of its evolution was surprising. We were just as surprised by the even-faster speed by which this variant spread. Omicron became the dominant variant almost two years into the pandemic because… Read More
Source: Timmerman ReportCategories: Latest Headlines, Oncologists1Tweet-
https://t.co/d2HuabaltJ
-
-
Mashup Score: 1Heterologous SARS-CoV-2 Vaccinations in Patients with B-cell Lymphoid Malignancies - PubMed - 2 year(s) ago
Heterologous SARS-CoV-2 Vaccinations in Patients with B-cell Lymphoid Malignancies
Source: PubMedCategories: Latest Headlines, Oncologists1Tweet-
What's possible when #CLL #lymphoma patients take the #CovidVaccine into their own hands? See what we at @UWMedicine @fredhutch @SeattleCCA found out: Heterologous Covid Vaccines in B-cell Lymphoma. https://t.co/MQcFTTKRWE @GreningerLab @mshadman @JoshuaHillMD @Rcl14L
-
Will be discussing "Dual-targeted regimens for the frontline treatment of #CLL" at #ASH23 @fredhutch @WomenInLymphoma @CllSociety https://t.co/DaeRHQZPIi